|
Rensin Chemicals Limited
|
Oseltamivir phosphate (OP) is a prodrug that is readily absorbed from the gastrointestinal tract after oral administration and is extensively converted predominantly by hepatic esterases to Oseltamivir carboxylate (OC)[1]. Oseltamivir phosphate is a widely used anti-influenza sialidase inhibitor. The metabolic activity of CMA07 and CMT-U27 cell lines is significantly decreased with 305 μM Oseltamivir phosphate treatment (p=0.005 and p<0.0001 respectively) using One Way ANOVA testes. In contrast, no statistically significant alterations are observed with 0.305 μM (p=0.9781), 3.05 μM (p=0.7436) and 30.5 μM (p=0.9623) of Oseltamivir phosphate treatments when compare with control cells. |
Send Inquiry
|
|
Zhuhai HRD Pharmaceutical Co., Ltd.
|
API for Oseltamivir phosphate1. HRD was founed in 2009, which has more than decades experience in Pharmaceutical industry;
2. HRD is a vertically integrated company for R&D, production and marketing;
3. We are stable supplying our intermediates&API to the global market and work with more than 20 countries'client;
4.Our new site is under construction currently, its design can meet the CGMP,EMA,USFDA standard for the international business, and it is expected to launch at the middle of 2022 for the API&Intermediates' production.
We are very strong for the intermediates of Oseltamivir Phosphate,Orlistat,Fluvoxamine maleate，Edoxaban,Fimasartan,IIaprazole,Vonoprazan Fumarate, Tavaborele, Ticagrelor and so on. |
Send Inquiry
|
Pharma Sources Insight January 2025
